ORACLE PARTNERS LP 4

4 · BIOLASE, INC · Filed Oct 31, 2019

Form 4

Period: 2019-10-29

10% Owner

Transactions

Purchase
Series E Preferred Stock
2019-10-29$57.50/sh+1,843$105,973→ 1,843 total(indirect: See footnote)
Purchase
Series E Preferred Stock
2019-10-29$57.50/sh+12,765$733,988→ 12,765 total(indirect: See footnote)
Purchase
Series E Preferred Stock
2019-10-29$57.50/sh+2,783$160,023→ 2,783 total(indirect: See footnote)

Footnotes (5)

[F1]These securities are owned by Oracle Partners, LP. ("Partners").
[F2]These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
[F3]These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners")
[F4]Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
[F5]Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.

Documents

1 file